SEC Filings

SEC Filings

Filing date	Description	Form	View
Dec 13, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-790936.pdf 0001193125-16-790936.rtf 0001193125-16-790936.xls
Dec 20, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-798635.pdf 0001193125-16-798635.rtf 0001193125-16-798635.xls
Dec 23, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-802787.pdf 0001193125-16-802787.rtf 0001193125-16-802787.xls
Dec 28, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-804999.pdf 0001193125-16-804999.rtf 0001193125-16-804999.xls
Dec 29, 2016	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-16-807318.pdf 0001193125-16-807318.rtf 0001193125-16-807318.xls
Dec 30, 2016	FWP	FWP	View HTML 0001193125-16-807685.pdf 0001193125-16-807685.rtf
Jan 05, 2017	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-17-002802.pdf 0001193125-17-002802.rtf 0001193125-17-002802.xls
Jan 05, 2017	FWP	FWP	View HTML 0001193125-17-002814.pdf 0001193125-17-002814.rtf 0001193125-17-002814.xls
Jan 09, 2017	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-17-004784.pdf 0001193125-17-004784.rtf 0001193125-17-004784.xls
Jan 11, 2017	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-17-007914.pdf 0001193125-17-007914.rtf 0001193125-17-007914.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE